Hexicon (chlorhexidine) vaginal suppositories 16 mg

Instructions for Hexicon (chlorhexidine) vaginal suppositories 16 mg vaginal suppositories

English Product Name
Hexicon

Features
Active ingredient Chlorhexidine
Dosage of active ingredient 16 mg
Instructions for use

Description Hexicon

The product may have white or white torpedo-shaped surface with a yellowish color tint. An air rod or funnel depression may be present on the surface of the product.

Active substances
Chlorhexidine

Release Form
Suppositories

Composition Hexicon
One suppository contains: active ingredient: chlorhexidine bigluconate solution 20% - 85.2 mg (in terms of chlorhexidine bigluconate - 16 mg), auxiliary substances: a mixture of macrogoles (Macrogol 1500, Macrogol 400).

• Nosology (ICD codes)
• A51
• Early syphilis
• A52
• Late syphilis
• A54
• Gonococcal infection
• A56.0
• Lower genitourinary chlamydial infections
• A56.1
• Chlamydial infections of pelvis and other genitourinary organs
• A59
• Trichomoniasis
• A60
• Anogenital herpetic virus infection [herpes simplex]
• N76
• Other inflammatory diseases of vagina and vulva

Pharmacological effect Hexicon

Drug Hexicone® is a topical antiseptic agent that is active against various types of bacteria, viruses including treponema pallidum, chlamidia spp., ureaplasma spp., neisseria gonorrhoeae, trichomonas vaginalis, gardnerella vaginalis, bacteroides fragilis, herpes-virus. Some strains of pseudomonas spp., proteus spp. have low drug sensitivity, as well as resistant acid-fast bacteria, bacterial spores, and fungi. Hexicone® does not affect the functional activity of lactobacilli. Its activity is maintained (albeit somewhat diminished) in the presence of blood and pus.

Pharmacokinetics Hexicon

When used vaginally, almost no absorption, does not have a systemic effect.

Testimony Hexicon

Prevention of sexually transmitted infections (chlamydia, ureaplasmosis, trichomoniasis, gonorrhea, syphilis, genital herpes, etc.). Preventing infectious and inflammatory complications in obstetrics and gynecology (before surgery for gynecological diseases, before delivery and abortion, before and after intrauterine device (IUD) insertion, before and after cervical diathermocoagulation, before intrauterine examinations). Treatment of bacterial vaginosis and vaginitis (including nonspecific, mixed, trichomonal)

Method of application and dose Hexicon

Intravaginal. The product is released from contour packaging prior to use. For treatment: 1 suppository twice a day, for 7-10 days. For prevention of sexually transmitted infections: 1 suppository within 2 hours of unprotected intercourse.